The medication reduces appetite and increases energy expenditure, but the degree of weight loss depends partly on what and how much you eat in the reduced-appetite state
A Certificate of Analysis (COA) is available for each product so researchers can verify what they receive
Considering the relationship between GLP-1 signaling and behavioral symptoms characteristic of depression, it was shown that intracerebroventricular ( icv ) administration of both GLP-1 and exendin-4 enhances associative and spatial learning, while these effects are inhibited by a GLP-1R antagonist
Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng EH, Judkins AR, et al
That is not an exaggeration